Paolini John F.
Reporting owner on Forms 3, 4 and 5, CIK 1741533.
Paolini John F. reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430 | officer (CHIEF MEDICAL OFFICER) | 2 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-13 | M exercised | +29,670 | $10.36 | 99,592 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-13 | M exercised | +4,994 | $11.1 | 104,586 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-13 | M exercised | +3,723 | $11.97 | 108,309 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-13 | M exercised | +3,144 | $12.97 | 111,453 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-13 | M exercised | +2,595 | $15.52 | 114,048 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-13 | M exercised | -29,670 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-13 | M exercised | -4,994 | $0 | 54,936 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-13 | M exercised | -3,723 | $0 | 56,207 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-13 | M exercised | -3,144 | $0 | 38,256 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-13 | M exercised | -2,595 | $0 | 47,405 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +6,455 | $30.93 | 76,377 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +11,958 | $17.92 | 88,335 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -899 | $92.37 | 87,436 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -16,810 | $93.42 | 70,626 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -704 | $94.09 | 69,922 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -6,455 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -11,958 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +38,545 | $30.93 | 108,467 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +39,042 | $17.92 | 147,509 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -41,789 | $92.02 | 105,720 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -16,056 | $92.85 | 89,664 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -6,841 | $93.91 | 82,823 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -4,821 | $94.86 | 78,002 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -4,000 | $95.97 | 74,002 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -1,925 | $97.06 | 72,077 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -2,155 | $97.77 | 69,922 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -38,545 | $0 | 6,455 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -39,042 | $0 | 11,958 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001741533-26-000014 | Kiniksa Pharmaceuticals International, plc | 2026-11-17 | ||
| Form 4 0001741533-26-000012 | Kiniksa Pharmaceuticals International, plc | 2026-11-03 |